Minerva Neurosciences Inc (NERV)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.43-5.54%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · NERV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||
| Revenues | — | — | — | 0.0 | 0.0 | 0.0 | 41.2 | 0.0 | 0.0 | 0.0 | — | — | — |
| Total Revenues | — | — | — | — | — | — | 41.2 | — | — | 0.0 | — | — | — |
| Operating Expenses & Income | |||||||||||||
| R&D Expenses | 15.5 | 5.8 | 11.9 | 12.7 | 14.6 | 32.0 | 22.0 | 58.1 | 34.9 | 30.3 | 20.4 | 18.5 | 42.9 |
| Operating Income | (35.1) | (15.1) | (21.8) | (23.1) | (25.2) | (45.4) | 1.8 | (75.9) | (51.7) | (41.2) | (30.2) | (26.1) | (54.9) |
| Earnings from Continuing Operations | |||||||||||||
| Interest & Investment Income | 1.9 | 0.9 | 1.3 | 1.4 | 0.6 | 0.0 | 0.2 | 1.5 | 1.7 | 0.9 | 0.2 | 0.1 | — |
| EBT, Incl. Unusual Items | — | — | — | — | (32.1) | (51.7) | 1.9 | (74.4) | (50.2) | (40.9) | — | — | — |
| Income Tax Expense | — | — | — | — | — | (1.8) | — | (2.3) | 0.0 | (9.4) | — | — | — |
| Net Income | |||||||||||||
| Net Income | (394.3) | (293.4) | 1.4 | (30.0) | (32.1) | (49.9) | 1.9 | (72.2) | (50.2) | (31.5) | (31.0) | (27.1) | (56.9) |
| Per Share | |||||||||||||
| Basic EPS | (8.46) | (34.67) | 0.19 | (4.61) | (6.01) | (9.35) | 0.05 | — | — | — | — | — | — |
| Diluted EPS | (4.99) | (34.67) | 0.19 | (4.61) | (6.01) | (9.35) | 0.05 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 46.6 | 8.5 | 7.6 | 6.5 | 5.3 | 5.3 | 40.8 | — | — | — | — | — | — |
| Diluted Weighted Avg Shares | 79.1 | 8.5 | 7.6 | 6.5 | 5.3 | 5.3 | 40.9 | — | — | — | — | — | — |
| Supplemental | |||||||||||||
| EBITDA | — | (15.1) | (21.8) | (23.1) | — | — | 1.9 | (75.8) | (51.7) | (41.2) | (30.2) | (26.1) | (54.8) |
| EBIT | (35.1) | (15.1) | (21.8) | (23.1) | (25.2) | (45.4) | 1.8 | (75.9) | (51.7) | (41.2) | (30.2) | (26.1) | (54.9) |
| Effective Tax Rate | — | — | — | — | — | 3.5% | — | 3.0% | 0.0% | 23.0% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.